The Harvard Crimson18h
Harvard, 10x Genomics Settle Patent Dispute With Vizgen
Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...
Analysts Set 10x Genomics, Inc. (NASDAQ:TXG) Target Price at $20.57
Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...
FierceBiotech1d
Roche rolls out new DNA 'sequencing-by-expansion' approach
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method ...
GEN1d
Roche Announces SBX Technology, Creates Sequencing Buzz
Roche introduces Sequencing by Expansion (SBX) technology in a webinar just a few days before the AGBT meeting takes place in Florida.
eLife3d
Multi-Omics Single-Cell Analysis Reveals Key Regulators of HIV-1 Persistence and Aberrant Host Immune Responses in Early Infection
This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...
MIT Technology Review3d
Adventures in the genetic time machine
Ancient DNA is telling us more and more about humans and environments long past. Could it also help rescue the future?
LexisNexis Announces “Top 100 Global Innovators” for 2025, Recognizing Leading Companies Driving Innovation in the Global Economy
LexisNexis ® Legal & Professional today announced the “Top 100 Global Innovators” for 2025, the prestigious roster of ...
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday
Genomics (NASDAQ:TXG – Get Free Report) is projected to announce its earnings results after the market closes on Thursday, February 20th. Analysts expect 10x Genomics to post earnings of ($0.29) per ...